For centuries, the field of pathology has been defined by a single instrument: the microscope. But according to William ...

VISTA, Calif., Dec. 9, 2025 /PRNewswire/ -- Leica Biosystems, a Danaher company and a global leader in anatomic pathology solutions, is driving the future of clinical diagnostics with another bold ...

Nomentia, Europe's leading provider of treasury and cash management solutions, today announced the appointment of Marc Vietor ...

Aiforia has signed an agreement with a world-renowned cancer institute in the United States to collaborate on AI-powered image analysis. The collaboration includes the use of the Aiforia’s AI training ...

NBEMS has launched a free six-month online AI course to help doctors improve diagnostics, decision-making and patient care ...

HOLX's Breast Health unit is back in focus as a proposed Blackstone-TPG deal adds a $76 cash offer and CVR to 2026-27 revenue goals.

GE HealthCare Technologies Inc. (NYSE: GEHC) leads with 100 FDA-approved AI devices, concentrating heavily on imaging and diagnostics. Their CleaRecon DL technology sharpens cone-beam CT images using ...

CorePlus announced the implementation of AIxURO, a state-of-the-art software solution that utilizes artificial intelligence to significantly improve the accuracy and efficiency of bladder cancer ...

Overview In 2026, AI startups revolve around practical problems rather than those linked to experimentation or hype.The four areas that appear to be growing mos ...

With shares well below recent highs, this ASX 200 stock is back on my radar. Here’s why I’m planning to buy it in 2026.

In 2025, India’s healthcare system balanced innovation with persistent strain. Overcrowded hospitals, rising chronic disease ...

Nvidia's restraint — focusing on enabling the ecosystem rather than owning it — has helped cement its role as the ...